TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Rowshan Medical AB
Closing information (x1000 DKK)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
114
|
271 | |
Financial expenses |
0
|
1 | |
Earnings before taxes |
103
|
257 | |
EBITDA |
102
|
258 | |
Total assets |
255
|
474 | |
Current assets |
255
|
474 | |
Current liabilities |
139
|
231 | |
Equity capital |
116
|
244 | |
- share capital |
34
|
33 | |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
45.5%
|
51.5% | |
Turnover per employee |
114
|
271 | |
Profit as a percentage of turnover |
90.4%
|
94.8% | |
Return on assets (ROA) |
40.4%
|
54.4% | |
Current ratio |
183.5%
|
205.2% | |
Return on equity (ROE) |
88.8%
|
105.3% | |
Change turnover |
-159
|
-108 | |
Change turnover % |
18%
|
-58%
|
-28% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.